Skip to content

Efficacy of Ethnic Marma Therapy and Wet Cupping Therapy in Grivasandhigata Vata w.s.r. to Cervical Spondylosis

Efficacy of Ethnic Marma Therapy and Wet Cupping Therapy in Grivasandhigata Vata w.s.r. to Cervical Spondylosis An open Labelled A Randomised Comparative Clinical Trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083716
Enrollment
30
Registered
2025-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy Health Condition 2: M488- Other specified spondylopathies

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed patients of Grivasandhi gate vats (cervical spondylosis) within the age group 20-60 years will be enrolled irrespective irrespective of sex , religion, occupation , socioeconomic status etc. 2.Patients who who are compulsory with Grivasandhi shoola ( cervical pain ) & Grivasandhi Stambha ( stiffness in cervical region). 3. Patients including Grivasandhi shoola & Grivasandhi Stambha & none of Grivasandhi shopha & Prasaran Akunchana Pavritti

Exclusion criteria

Exclusion criteria: 1. Age below 20 years and above 60 years. 2. Patients with uncontrolled diabetes (RBS greater than 140mg/dl) and uncontrolled hypertension (BP greater than 160/90mmHg) 3. Tuberculosis of cervical spine & malignancy. 4. Patients with cervical rib, Fracture of Cervical Spine. 5. Other diseases like cardiac diseases, renal diseases and endocrine diseases, and severe Anaemia and immunosuppressive disorders, Serology Positive patients. 6. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
1.Relief in pain and stiffness of Cervical Spondylosis. 2.Painless increased Angle to of the Movement ( AOM).Timepoint: 4 weeks

Secondary

MeasureTime frame
Cost effective Time saving Minimum facilities required Minimize side effects Non pharmacologicalTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDr P B JOSHI

Institute of Teaching and Research in Ayurveda

pbj@itra.edu.in9427226504

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026